Request a second opinion

What a second opinion actually is

A cancer second opinion is a formal review of a patient’s diagnosis and treatment plan by a specialist who was not part of the first consultation. The review usually covers three things: whether the diagnosis is correct, whether the stage is correct, and whether the recommended treatment is the best option for that person at that moment. A good second opinion is not an argument against the first doctor. It is a structured check, done by someone who sees this disease often, before the family commits time, money, and the body to a long course of treatment. [1][2]

In India, second opinions happen in several shapes. One is the walk-in OPD review at a tertiary cancer centre such as leading cancer centres, or a large private oncology group, where the patient carries slides, blocks, imaging CDs, and reports for a fresh read. Another is the online or email second opinion, where scanned reports and uploaded images are reviewed and a written note is sent back. A third, and this is the one most Indian patients do not realise exists, is the multi-disciplinary tumour board review, where a surgical oncologist, a medical oncologist, a radiation oncologist, a pathologist, and a radiologist all discuss the same case together and produce a single joint plan. [4][5][7]

HealOnco offers a second opinion service built around the third model. When you bring us a case, we arrange for a pathology re-read, an imaging re-read, and a multi-disciplinary discussion by our medical, surgical, and radiation oncology consultants. You leave with a written plan, a clear explanation of why, and a direct answer to the one question most families actually came to ask: is this the right treatment, and do we really need to start it today.

Why a second opinion matters in cancer specifically

Cancer is different from most other medical problems for one reason. The decisions made in the first two or three weeks after diagnosis set the direction for the next one to five years of treatment. A wrong call at the start is expensive to undo. If the wrong primary site is named, the entire chemotherapy regimen can be off-label. If the receptor status on a breast biopsy is read incorrectly, a patient may be put on hormonal therapy that will not work, or, worse, denied HER2-directed therapy that could change outcome. If the stage is under-called, curative surgery may be skipped when it should have been offered. If the stage is over-called, a patient may be sent to palliative care when long remission was still on the table. [1][3][10]

Pathology is where the most consequential changes happen. Published series from large academic centres, including CAP-referenced reviews and single-institution series in JCO, report that expert pathology re-review changes the primary diagnosis or grade in a clinically meaningful minority of referred cases, and alters management in a somewhat smaller but still non-trivial fraction. [9][10] Indian tertiary-centre series, published in the Indian Journal of Cancer and similar journals, report the same pattern on slides sent in from community labs. [11]

Imaging is the second place. A PET-CT or MRI re-read by a dedicated oncology radiologist can change nodal status, change the presence or absence of liver or bone metastases, and change the T stage in rectal cancer or the resectability call in pancreatic cancer. The raw images are the same. The interpretation is not.

And then there is the plan itself. Even with a correct diagnosis and correct stage, two oncologists can legitimately disagree on sequencing (surgery first versus chemotherapy first), on regimen (FOLFIRINOX versus gemcitabine-nab-paclitaxel in pancreatic cancer), on the role of radiation, and on the use of a targeted or immunotherapy drug. None of this is malpractice. It is what oncology actually looks like. A second opinion makes those choices visible to the patient, which is the point. [2][6]

When to ask for a second opinion

Ask for a second opinion if any of the following is true. You do not need all of them. One is enough.

• The cancer is rare. Sarcoma, neuroendocrine tumours, thymic tumours, gestational trophoblastic disease, adrenocortical carcinoma, and most paediatric cancers should be reviewed at a high-volume centre.
• The cancer is common but the plan feels aggressive. If a stage I breast cancer is being pushed toward mastectomy without a lumpectomy discussion, review. If a low-risk prostate cancer is being pushed straight to surgery without an active surveillance discussion, review.
• You have been told the cancer is not treatable. Stage IV does not always mean short survival, and published outcomes in HER2-positive metastatic breast cancer, oligometastatic colorectal cancer, ALK-rearranged lung cancer, and certain lymphomas and leukaemias have all shifted meaningfully over the last decade. Before accepting a palliative-only plan, get a second set of eyes. [2][6]
• The recommended treatment is long, expensive, or has heavy side effects. Six months of FOLFIRINOX, a year of trastuzumab, an autologous transplant, a radical cystectomy, any of these deserve a fresh look.
• The diagnosis was made on a small or difficult sample. Fine-needle aspirates, tiny core biopsies, and pleural or ascitic fluid cytology are all harder to read than a generous surgical biopsy.
• The first doctor seems unsure, or keeps changing the plan, or is relying on a treatment they have never personally done much of.
• You want to be part of a clinical trial. Trials are concentrated at a small number of Indian centres.
• You simply want to be sure. No good oncologist takes offence at a patient asking for a second opinion. [1][2]

What a second opinion does not mean

A second opinion does not mean you distrust your first doctor. Good oncologists expect it and often encourage it, especially for complex disease. A second opinion does not mean you are switching care. Many patients take a plan home from a tertiary centre and carry it out locally, which is often the most practical path. A second opinion does not mean starting from zero. The whole point of carrying slides and imaging is that the diagnostic work does not have to be repeated. And a second opinion is not a tie-breaker. If two oncologists disagree, the right move is usually a multi-disciplinary tumour board, not a third opinion, and not a coin toss.

How a HealOnco second opinion runs

1. First call. You reach us through the site form, WhatsApp, or phone. We ask for the diagnosis, the current plan, and which city you are in. We tell you what paperwork to bring.
2. Document pull. Biopsy report, IHC, imaging reports and DICOM, recent blood work, discharge summaries, and the first doctor’s written plan. Slides and paraffin blocks where available.
3. Pathology re-read. Our pathology partner reviews H and E slides, re-runs IHC if needed, and repeats molecular testing when the first panel missed something clinically important. [9][10][11]
4. Imaging re-read. A dedicated oncology radiologist re-reads the PET-CT, MRI, or CECT and writes a structured report.
5. Multi-disciplinary discussion. Medical, surgical, and radiation oncology review the case together, or at the next weekly tumour board. For rare cases we loop in a subspecialist through the NCG virtual tumour board. [7]
6. Written plan. A plain-language note with corrected diagnosis if any, stage, recommended treatment, alternatives, cost range, duration, and named guideline evidence.
7. A real conversation. A consultant sits with the family and walks through the plan.
8. Follow-up. If you take the plan back to your first hospital, we send the note and stay available.

Typical turnaround for an in-person second opinion is one working day once all documents are in hand. Online second opinions take two to four working days.

What you need to bring

• Government ID for the patient.
• The biopsy or histopathology report (every page).
• The IHC report if done.
• Molecular testing reports: ER/PR/HER2, EGFR, ALK, ROS1, BRAF, KRAS, MSI/MMR, PD-L1, BCR-ABL1, FLT3, NPM1, IDH1/IDH2, 1p/19q, MGMT, BRCA1/2.
• Paraffin blocks and stained slides from the biopsy, if the first lab will release them.
• All imaging: PET-CT, MRI, CECT, mammogram, ultrasound, bone scan, with actual images on CD, USB, or DICOM.
• Blood work from the last four weeks: CBC, LFT, KFT, electrolytes, tumour markers (CEA, CA 19-9, CA 125, AFP, PSA, beta-a leading cancer centre, LDH, beta-2 microglobulin) where relevant.
• Operation notes, discharge summaries, and the first doctor’s written plan.
• A one-page medical history: other illnesses, current medicines, allergies, prior cancers, family history.
• If already on treatment: the chemotherapy protocol sheet, cycle dates, and current side-effect profile.

Pathology re-review: the part that changes the most plans

Pathology re-review is where second opinions earn their keep. CAP-reported data and JCO case series describe meaningful rates of change in primary diagnosis, grade, or subclassification when community-lab slides are reviewed by subspecialist pathologists at high-volume centres, with a smaller but clinically important fraction leading to a change in the actual treatment plan. [9][10] Indian tertiary-centre series from a tertiary cancer centre and a tertiary cancer centre report the same pattern on slides sent in from smaller hospitals. [4][5][11]

Re-review changes outcomes for specific reasons: subtype (invasive ductal versus invasive lobular breast cancer, adenocarcinoma versus squamous lung, DLBCL versus high-grade B-cell with MYC/BCL2 rearrangement); grade (which drives systemic therapy in sarcoma, prostate, and breast cancer); receptor and driver status (ER, PR, HER2, EGFR, ALK, BRAF, KRAS G12C, BRCA1/2, MSI, PD-L1); and margin status on a resection specimen. [10][11]

Imaging re-review

A radiologist who reports ten cancer scans a week reads a staging CT differently from one who reports two cancer scans a year. Re-review routinely finds small liver metastases, peritoneal deposits, retrocrural nodes, or sub-centimetre lung nodules that were missed, and downgrades findings that were over-called (reactive nodes, haemangiomas, benign adrenal adenomas), which can flip a patient from stage IV back to stage III and back into curative intent. [6]

In rectal cancer, MRI re-read changes T stage and circumferential margin call often enough that NCCN recommends it. In pancreatic cancer, the resectable/borderline/locally advanced distinction is image-based and decides whether curative surgery is offered. In HCC, LI-RADS categorisation decides whether you treat without a biopsy. In head and neck cancer, a second primary or contralateral node reroutes radiation fields.

Multi-disciplinary tumour board review

A multi-disciplinary tumour board (MDT) is the reference standard for cancer decisions. It is how high-volume centres work, and it is how the National Cancer Grid in India organises cross-institution second opinions through its weekly virtual tumour boards. [7] In the MDT, a surgical oncologist, medical oncologist, radiation oncologist, pathologist, and radiologist look at the same data at the same time and argue toward a single plan. Where they disagree, they say why. The plan is written down and signed off. For HealOnco, the MDT is the spine of the second opinion service.

Online vs in-person second opinion

In-person is better when slides and blocks need to be re-cut, when a repeat biopsy may be needed, or when the family wants the longer conversation in one sitting. Online is better when the patient is outside the city, when the documentation is complete, or when the question is narrow. For online, scanned reports and DICOM uploads go through our secure portal, a written note comes back inside two to four working days, and a video call with the reviewing consultant is included.

Cost of a second opinion in India, 2026

Scenario	What is included	Typical ₹ range	Turnaround
Walk-in OPD, common cancer	Consultation + review of existing reports	₹1,000 – ₹3,000	Same day
MDT second opinion, common cancer	Pathology re-read, imaging re-read, MDT, written plan	₹5,000 – ₹15,000	1 – 2 working days
MDT second opinion, rare / complex	Plus subspecialist pathology and NCG virtual board	₹10,000 – ₹25,000	2 – 5 working days
Online second opinion, common cancer	Review of uploads, written plan, video call	₹3,000 – ₹8,000	2 – 4 working days
Online second opinion, rare cancer	Plus subspecialist review	₹8,000 – ₹20,000	3 – 7 working days
Pathology re-review only	H and E review, selective IHC, written report	₹3,000 – ₹12,000	2 – 4 working days
Repeat molecular testing (NGS)	Solid-tumour or haem panel	₹25,000 – ₹1,20,000	7 – 14 working days
Repeat imaging (only if inadequate)	PET-CT / CECT / MRI	₹8,000 – ₹30,000	Same day report

Most Indian private health policies now include a second medical opinion benefit for listed critical illnesses. [12] Ayushman Bharat PMJAY covers an OPD review at empanelled hospitals. Call us before your visit and we will tell you exactly what is covered for your plan.

Practical barriers, and how to get around them

The biggest barrier is the perception of disloyalty to the first doctor. Any doctor who takes offence at a second opinion request is a doctor the patient should not stay with. Good oncology is team oncology. [2]

Document release is the second barrier. Some hospitals are slow to release slides, blocks, or imaging CDs. A formal written request from the patient, countersigned by the new consultant, usually works. We draft this letter for every HealOnco second opinion patient who asks.

Cost is the third. The second opinion fee is almost always a fraction of one percent of the total treatment cost, and it is the single highest-return amount spent in the entire course. Catching a wrong diagnosis or a wrong plan at this stage saves lakhs later.

Distance is the fourth. The NCG virtual tumour board connects community oncologists to subspecialist teams across 300+ Indian centres. [7] For HealOnco patients, the online second opinion service was built for the same constraint.

Red flags in a first plan that should push you toward a second opinion

• The stage on paper does not match what the scans actually show, or a staging scan was never done.
• IHC or molecular testing that NCCN or ESMO consider mandatory was not ordered. Common misses: HER2 on gastric and oesophageal cancer, MSI on colorectal cancer, PD-L1 on lung cancer, driver mutations on NSCLC, BRCA on ovarian and metastatic prostate cancer.
• The recommended chemotherapy regimen is not a first-line option in current guidelines.
• Curative surgery was skipped or delayed without a written reason.
• Radiation therapy was recommended without an MDT discussion in a disease where surgery is also standard.
• A stage IV diagnosis was made on imaging alone without biopsy confirmation.
• Palliative care was offered with no discussion of systemic therapy options where active treatment still has published benefit.
• The patient was told there are no clinical trials without anyone actually checking the Clinical Trials Registry India.

How to choose the right second opinion provider

Look for four things. First, a named oncology subspecialty, not a general oncology or general surgery service. Second, access to a pathology re-read capability, in-house or through a named partner lab. Third, a multi-disciplinary tumour board, not just a single doctor. Fourth, a written plan at the end, with named evidence.

High-volume public sector options include a tertiary cancer centre Mumbai, a tertiary cancer centre New Delhi, a tertiary cancer centre Bengaluru, Cancer Institute WIA Chennai, a tertiary cancer centre Kolkata, a tertiary cancer centre Thiruvananthapuram, and the network of regional cancer centres under the National Cancer Grid. [4][5][7]

What HealOnco second opinion includes

A named medical oncologist and surgical oncologist consultation. Pathology re-read on existing slides by our oncopathology partner, with IHC repeated if needed. Imaging re-read by our oncology radiologist. A multi-disciplinary tumour board discussion within one to two working days, with a radiation oncologist included where relevant. A written plan in English (and in Hindi or Punjabi on request), with named guidelines cited. A sit-down conversation with the family. A follow-up call at seven days. A short note for the first doctor summarising our suggestions, if the plan is taken back. We stay reachable for questions during treatment. Not included: repeat biopsy, repeat molecular testing, and repeat imaging, each quoted separately and only if the existing work is inadequate.

Our oncologists

HealOnco second opinions are delivered by a panel of medical, surgical, and radiation oncology consultants, with pathology and radiology partners. Named consultant profiles are listed on our doctors directory.

Our centers

HealOnco Chandigarh is our flagship daycare oncology center. City hubs in Delhi, Gurgaon, Noida, Faridabad, Ghaziabad, Mumbai, Bengaluru, Hyderabad, Chennai, Kolkata, and Pune carry the same second opinion workflow.

Patient testimonials

Families tell us the second opinion conversation was the first time they felt someone explained the plan in full. Testimonials are collected after treatment with written consent and published on our patient stories page.

Frequently asked questions

Will my first doctor be upset if I get a second opinion? Most will not. Second opinions are standard practice in cancer and are openly recommended by NCI, ASCO, and ESMO in their patient guides. [1][2][6]

Do I have to pay again for all the tests? Usually no. The whole point of carrying slides, blocks, and imaging is to avoid repeating tests.

How long does it take? Walk-in second opinions for common cancers finish the same day. MDT second opinions take one to two working days. Online second opinions take two to four working days.

Can I do the second opinion online if I cannot travel? Yes. Upload reports and images through our portal. The written plan comes back in two to four working days with a video call included.

Will the second opinion be different from the first one? Sometimes. Published series describe meaningful changes in diagnosis, grade, or plan in a clinically important minority of referred cases. [9][10]

Does my insurance cover this? Most Indian private health policies now include a second medical opinion benefit for listed critical illnesses. [12] Ayushman Bharat PMJAY covers an OPD review at empanelled hospitals.

Can I get a second opinion if I have already started chemotherapy? Yes, and in some cases you should. Bring the protocol sheet, cycle dates, and current side-effect profile.

Can I get a second opinion for a family member who cannot travel? Yes, with written consent from the patient or legal next of kin.

Can I bring a recording device? Yes. We encourage it. Recording lets everyone at home hear the plan in the doctor’s own words.

What if the two opinions disagree? The right move is a joint MDT discussion, which the NCG virtual board supports by looping in the first doctor or a third subspecialist. [7]

Can you help me find a clinical trial? Yes. We check the Clinical Trials Registry India, the trial lists at major Indian academic centres, and international trials with an Indian site.

What if I want to continue treatment with my first doctor? That is perfectly fine. The written plan goes with you, and we stay available for questions.

My cancer is very rare. Is a second opinion still useful? Especially then. NCCN and ESMO both recommend referral for rare cancers. [3][6]

How soon after diagnosis should I get a second opinion? Ideally before starting treatment. For most solid tumours, you have one to three weeks of safe decision-making time after the biopsy report. For aggressive haematological cancers, the window is shorter.

Is a second opinion the same as an online consultation? No. An online consultation is a single doctor looking at your reports. A true second opinion is a structured MDT review ending with a written plan and named guidelines.

The bottom line

A cancer second opinion is not about distrust. It is about making sure a long, expensive, and physically hard treatment course is the right one before it starts. The highest-value second opinion in India today is a multi-disciplinary review that includes pathology re-read, imaging re-read, and a tumour board discussion, delivered in one to two working days with a written plan at the end.

Second opinion in top Indian cities

• Second opinion in Delhi
• Second opinion in Gurgaon
• Second opinion in Noida
• Second opinion in Faridabad
• Second opinion in Ghaziabad
• Second opinion in Mumbai
• Second opinion in Bengaluru
• Second opinion in Hyderabad
• Second opinion in Chennai
• Second opinion in Kolkata
• Second opinion in Pune

Second opinion cost in top Indian cities

• Second opinion cost in Delhi
• Second opinion cost in Gurgaon
• Second opinion cost in Noida
• Second opinion cost in Faridabad
• Second opinion cost in Ghaziabad
• Second opinion cost in Mumbai
• Second opinion cost in Bengaluru
• Second opinion cost in Hyderabad
• Second opinion cost in Chennai
• Second opinion cost in Kolkata
• Second opinion cost in Pune

Related supportive care

• Pain management
• Nutrition
• Counseling
• Physiotherapy
• Palliative care

References

1. National Cancer Institute (cancer.gov), patient education, “Getting a Second Opinion Before Surgery” and related pages.
2. American Society of Clinical Oncology, cancer.net, “Seeking a Second Opinion.”
3. NCCN Patient Guidelines, general statement on specialist review for complex cancers.
4. a tertiary cancer centre, Mumbai: second opinion clinic and online second opinion service.
5. a tertiary cancer centre, New Delhi: oncology OPD second opinion workflow.
6. European Society for Medical Oncology (ESMO), patient guide series.
7. National Cancer Grid of India (NCG): virtual tumour board programme across 300+ Indian centres.
8. World Health Organization, Global Initiative for Cancer Registry Development.
9. College of American Pathologists: data on pathology re-review and diagnostic discordance in oncology specimens.
10. Journal of Clinical Oncology: case series on expert pathology re-review changing primary diagnosis, grade, or management.
11. Indian Journal of Cancer and Indian Journal of Medical and Paediatric Oncology: single-centre Indian series on outside-slide review.
12. Insurance Regulatory and Development Authority of India (IRDAI): product guidance on second medical opinion benefits.